Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q1 2018 · 10-Q
Revenue—
Net Income-$1.36M-$1.36MN/M vs Q1 2017 EPS Diluted-$0.17-$0.17N/M vs Q1 2017 Operating Income-$1,097,480N/M Operating Cash Flow-$591,269N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 16, 2018 · 46 d after period end